Follow
Jeannette Lechner-Scott
Jeannette Lechner-Scott
Hunter Medical Research Institute
Verified email at health.nsw.gov.au
Title
Cited by
Cited by
Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
26272011
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
17512012
Rate of pregnancy-related relapse in multiple sclerosis
C Confavreux, M Hutchinson, MM Hours, P Cortinovis-Tourniaire, ...
New England Journal of Medicine 339 (5), 285-291, 1998
17281998
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
11222013
Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F‐fluorodeoxyglucose positron emission tomography study
U Roelcke, L Kappos, J Lechner-Scott, H Brunnschweiler, S Huber, ...
Neurology 48 (6), 1566-1571, 1997
5621997
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
C Confavreux, P O'Connor, G Comi, MS Freedman, AE Miller, TP Olsson, ...
The Lancet Neurology 13 (3), 247-256, 2014
5412014
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ...
Nature genetics 41 (7), 824-828, 2009
5052009
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
4172019
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
S Ramanathan, S Mohammad, E Tantsis, TK Nguyen, V Merheb, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 127-137, 2018
3542018
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
2672019
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood
MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ...
PloS one 5 (8), e12132, 2010
2672010
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
2412016
Computer assisted retraining of attentional impairments in patients with multiple sclerosis
AM Plohmann, L Kappos, W Ammann, A Thordai, A Wittwer, S Huber, ...
Journal of Neurology, Neurosurgery & Psychiatry 64 (4), 455-462, 1998
2311998
Geographical variations in sex ratio trends over time in multiple sclerosis
M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ...
PLOS one 7 (10), e48078, 2012
2222012
The COVID-19 pandemic and the use of MS disease-modifying therapies
G Giovannoni, C Hawkes, J Lechner-Scott, M Levy, E Waubant, J Gold
Multiple sclerosis and related disorders 39, 2020
1702020
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis
T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ...
Annals of Neurology 77 (3), 425-435, 2015
1592015
Predictors and dynamics of postpartum relapses in women with multiple sclerosis
SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ...
Multiple Sclerosis Journal 20 (6), 739-746, 2014
1532014
Can the Expanded Disability Status Scale be assessed by telephone?
J Lechner-Scott, L Kappos, M Hofman, CH Polman, H Ronner, ...
Multiple Sclerosis Journal 9 (2), 154-159, 2003
1512003
Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis
VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ...
Annals of neurology 80 (1), 89-100, 2016
1502016
Defining reliable disability outcomes in multiple sclerosis
T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ...
Brain 138 (11), 3287-3298, 2015
1412015
The system can't perform the operation now. Try again later.
Articles 1–20